When the eyelash enhancing drug Latisse was first
approved by the Food and Drug Administration more than two years
ago, one of the big concerns was hair growth on the eyelids and
around the eyes in those who were a little messy when applying the
liquidy substance.
Latisse's hair growth potential has probably led some doctors to
start prescribing the treatment "off-label" for baldness, ABC News
reports. One woman said she used the treatment to restore her
over-plucked eyebrows before her wedding.
And those treating baldness with the only two prescription remedies
on the market -- Rogaine (a lotion) and Propecia (a pill) -- agreed
that it would be nice to add a third.
But, like all drugs, Latisse has some side effects like eye
irritation, skin redness, and the potential to alter the pigment of
the eye turning, say, blue eyes, brown.
Actress Claire Danes, pitching the product in the commercial posted
above, said on the Latisse website that she initially had some skin
irritation that went away after about a week.
It's not known whether these same side effects -- or different ones
-- would occur from rubbing a whole lot of Latisse into the scalp to
help hair grow.
Allergan, maker of Latisse, is starting clinical trials in June to
test Latisse for the treatment of baldness, according to an email
sent to me by Allergan vice president Caroline Van Hove. "We cannot
comment on its potential efficacy or safety...at this time," she
said, but the company is hoping to have FDA approval by 2013.
Back to hair loss news
Copyright stophairlossnow.co.uk